Clinical Care
Specialised imaging for better-informed clinical decisions
We provide interpretation and reporting services for prostate and genitourinary imaging studies, including magnetic resonance imaging, computed tomography and nuclear medicine techniques.
We focus especially on diagnostic scenarios that require subspecialised expertise and the integration of different imaging modalities.
Our goal is to deliver accurate, structured and clinically useful reports that answer the specific question of the requesting professional and support decision-making.
Who is it for?
Hospitals, diagnostic centres, clinics and professionals who need specialised support to interpret complex studies, integrate different imaging modalities or strengthen their care capacity.
Areas of work
Prostate imaging: detection, local staging, active surveillance, treatment planning, post-treatment assessment and suspected recurrence.
Genitourinary imaging: specialised assessment of urinary and genital conditions, male and female, both oncological and non-oncological.
Nuclear medicine and hybrid imaging: PSMA PET-CT, choline PET-CT, other PET-CT studies and PET-MRI.
Assessment and follow-up of genitourinary oncological diseases.
Integration of findings from magnetic resonance imaging, computed tomography and nuclear medicine.
Correlation with clinical history, pathology and previous studies.
Application of standardised interpretation and classification systems.
How we work
- Receipt of DICOM images and clinical information.
- Verification of the technical quality and suitability of the study.
- Interpretation by professionals subspecialised in prostate imaging, genitourinary imaging or nuclear medicine.
- Integration of the different imaging modalities available.
- Preparation of a structured report geared towards clinical decision-making.
- Communication with the requesting professional when the case requires further discussion.
- We take part in multidisciplinary sessions whenever possible.
Our clinical activity
Uroima works with a range of healthcare groups and diagnostic centres in Spain and Latin America, providing specialised expertise in prostate and genitourinary imaging.
In Catalonia and Aragon, we carry out our clinical activity in the Uro-Radiology area through an exclusive collaboration agreement with Creu Blanca.
Uroima and Creu Blanca in figures
3,750
Prostate MRIs reported per year
All analysed with the support of artificial intelligence and reported by professionals with a high level of subspecialisation in prostate imaging.
840
Fusion prostate biopsies per year
Pioneers in Barcelona since 2018, with a high-volume care pathway run by a team of radiologists and urologists who are experts in prostate disease. Radiological segmentation and urological biopsy are integrated into a single process to achieve precise localisation and sampling of lesions.
Experience, technology and teamwork
Close collaboration between radiology and urology makes it possible to precisely locate suspicious lesions, plan the procedure and direct the biopsy to the areas of greatest clinical relevance.
This interdisciplinary model, backed by a high volume of activity and years of experience, is one of the main distinguishing strengths of Uroima + Creu Blanca.
